J. B. Chemicals & Pharmaceuticals Limited (BSE: 506943)
Health Care · Pharmaceuticals · IN
Rs—
— today · — 1Y
J. B. Chemicals & Pharmaceuticals Limited (BSE: 506943) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $4.02B.
trading between 1.60K and 2.51K.
Tweenvest scores J. B. Chemicals & Pharmaceuticals Limited across four factors: quality 87/100, value 8/100, growth 64/100, dividend 75/100. Its strongest factor is quality.
506943 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $4.02B
- Revenue (TTM)
- $442.35M
- P/E
- 54.27
- EPS
- 44.45
- Dividend yield
- 0.91%
- Beta (5Y)
- 0.04
- 52-week high
- Rs2,509.40
- 52-week low
- Rs1,603.05
- Avg volume (3M)
- —
- Shares outstanding
- 160.56M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Edgewise Therapeutics, Inc.NasdaqGS: EWTX | $4.30B | $39.75 | +0.45% |
| Indivior Pharmaceuticals, Inc.NasdaqGS: INDV | $4.26B | $36.00 | -0.36% |
| Aspen Pharmacare Holdings LimitedJSE: APN | $4.26B | R160.00 | +1.90% |
| Yuhan CorporationKOSE: A000100 | $4.11B | ₩74,100.00 | -2.37% |
| Caliway Biopharmaceuticals Co., Ltd.TWSE: 6919 | $3.90B | NT$79.90 | -0.25% |
| Hypera S.A.BOVESPA: HYPE3 | $3.85B | R$27.32 | +1.19% |
| Emcure Pharmaceuticals LimitedNSEI: EMCURE | $3.83B | Rs1,944.60 | -0.31% |
| Shijiazhuang Yiling Pharmaceutical Co., Ltd.SZSE: 002603 | $3.82B | CN¥15.35 | +1.39% |
Figures last refreshed Oct 4, 2026.